Literature DB >> 22194291

Impact of relative humidity and collection media on mycobacteriophage D29 aerosol.

Keyang Liu1, Zhanbo Wen, Na Li, Wenhui Yang, Jie Wang, Lingfei Hu, Xiaokai Dong, Jianchun Lu, Jinsong Li.   

Abstract

This study was conducted to evaluate the effect of aerosol generation, methods of sampling, storage conditions, and relative humidity on the culturability of the mycobacteriophage D29. The lytic phage D29 can kill Mycobacterium tuberculosis, and the phage aerosol can be treated as a potential tool for tuberculosis treatment. The culturability of D29 was tested using a test chamber designed for the bioaerosols research against three spray liquids (deionized water, phosphate-buffered saline [PBS], and normal saline), four collection media (suspension medium [SM], nutrient broth, PBS, and deionized water), two sampling systems (the all-glass impinger AGI-30 and the Biosampler) and across a range of humidities (20 to 90%). The effect of storage conditions on the culturability of collected sample was also evaluated for the AGI-30 impinger. The results proved that viable phage D29 particles generated by deionized water were approximately 30- and 300-fold higher than PBS and normal saline, respectively. As collection media, SM buffer and nutrient broth were observed to yield a higher number of plaques compared to PBS and deionized water. No difference was observed in collection efficiency between AGI-30 and Biosampler with two detection methods (culture-based technique and real-time PCR). The culturability of collected D29 in SM buffer or nutrient broth can be maintained up to 12 h irrespective of storage temperature. Relative humidity was found to strongly influence airborne D29 culturability which is 2- to 20-fold higher in low humidity (25%) than medium (55%) or high (85%) humidity. This research will help identify the optimal means for the application of D29 aerosol in animal inhalation experiments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22194291      PMCID: PMC3294485          DOI: 10.1128/AEM.06610-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  48 in total

1.  Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

Authors:  Caroline Westwater; Laura M Kasman; David A Schofield; Phillip A Werner; Joseph W Dolan; Michael G Schmidt; James S Norris
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

2.  Comparison of bioaerosol sampling methods in barns housing swine.

Authors:  P S Thorne; M S Kiekhaefer; P Whitten; K J Donham
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

3.  Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates.

Authors:  N Galí; J Domínguez; S Blanco; C Prat; M D Quesada; L Matas; V Ausina
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

4.  [Pathomorphological assessment of the therapeutic effect of mycobacteriophages in tuberculosis].

Authors:  Z S Zemskova; I R Dorozhkova
Journal:  Probl Tuberk       Date:  1991

5.  Fate of bacteriophage lambda in non-immune germ-free mice.

Authors:  M R Geier; M E Trigg; C R Merril
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

6.  Enhanced recovery of airborne T3 coliphage and Pasteurella pestis bacteriophage by means of a presampling humidification technique.

Authors:  M T Hatch; J C Warren
Journal:  Appl Microbiol       Date:  1969-05

Review 7.  Comparative deposition of inhaled aerosols in experimental animals and humans: a review.

Authors:  R B Schlesinger
Journal:  J Toxicol Environ Health       Date:  1985

8.  Sampling submicron T1 bacteriophage aerosols.

Authors:  J B Harstad
Journal:  Appl Microbiol       Date:  1965-11

9.  Effect of relative humidity on the airborne survival of rotavirus SA11.

Authors:  S A Sattar; M K Ijaz; C M Johnson-Lussenburg; V S Springthorpe
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

10.  Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21 T, My-327.

Authors:  L Sula; J Sulová; M Stolcpartová
Journal:  Czech Med       Date:  1981
View more
  6 in total

Review 1.  Phage therapy for respiratory infections.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Yu Lin; Sharon Sui Yee Leung; Hui Wang; Sandra Morales; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2018-08-07       Impact factor: 15.470

2.  Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler.

Authors:  Nicholas B Carrigy; Rachel Y Chang; Sharon S Y Leung; Melissa Harrison; Zaritza Petrova; Welkin H Pope; Graham F Hatfull; Warwick J Britton; Hak-Kim Chan; Dominic Sauvageau; Warren H Finlay; Reinhard Vehring
Journal:  Pharm Res       Date:  2017-06-23       Impact factor: 4.200

3.  Bioaerosol Sampling: Classical Approaches, Advances, and Perspectives.

Authors:  Gediminas Mainelis
Journal:  Aerosol Sci Technol       Date:  2019-10-04       Impact factor: 4.809

4.  Effect of selected sampling media, flow rate, and time on the sampling efficiency of a liquid impinger packed with glass beads for the collection of airborne viruses.

Authors:  Yen-Chi Chen; I-Jen Wang; Chih-Ching Cheng; Yu-Chiao Wu; Chun-Hsuan Bai; Kuo-Pin Yu
Journal:  Aerobiologia (Bologna)       Date:  2021-01-13       Impact factor: 2.376

Review 5.  Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections.

Authors:  Xiang Wang; Zuozhou Xie; Jinhong Zhao; Zhenghua Zhu; Chen Yang; Yi Liu
Journal:  Front Cell Infect Microbiol       Date:  2021-12-06       Impact factor: 5.293

6.  Improving the collection efficiency of the liquid impinger for ultrafine particles and viral aerosols by applying granular bed filtration.

Authors:  Kuo-Pin Yu; Yen-Ping Chen; Jia-You Gong; Yen-Chi Chen; Chih-Ching Cheng
Journal:  J Aerosol Sci       Date:  2016-08-16       Impact factor: 3.433

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.